Volato Secures $2.2 Million Investment for AI Pivot as Shares Fall 23%
SOAR•Volato Group raised $2.2 million from Catheter Precision via restricted stock to boost its balance sheet and shift focus from a terminated critical-minerals merger to AI infrastructure, software and power-generation projects. SOAR shares slid 23% premarket as management cited two unsolicited AI deal letters and awaits NYSE American approval.
1. Strategic Investment and AI Pivot
Volato Group secured a $2.2 million strategic investment led by Catheter Precision through restricted common stock to strengthen its balance sheet and fund a shift from a terminated critical-minerals merger to opportunities in AI infrastructure, software, data centers, compute and power generation.
2. Share Reaction and Market Impact
SOAR shares declined 23% in premarket trading as investors processed the company’s new direction, evaluating potential dilution impact and the timeline for NYSE American’s supplemental listing approval.
3. Merger Termination and AI Deal Inquiries
The company formally ended its M2i Global critical-minerals deal but maintains compliance plan milestones and has received two unsolicited non-binding letters of intent related to AI ecosystem transactions, though no definitive agreements have been executed.
